CompaniesByCap
MCRB
Seres Therapeutics, Inc. (MCRB)
NASDAQ · Healthcare

Seres Therapeutics, Inc. Income Statement 2015–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015
Revenues
Revenue789,000007.1M143.9M11.9M27.2M26.9M32.1M21.8M0
Gross Profit
Profitability
Operating Income-94.0M-121.3M-195.1M-179.9M-64.5M-88.1M-71.9M-100.3M-91.4M-92.8M-54.9M
EBITDA-89.8M-115.8M-188.9M-173.3M-58.5M-81.6M-64.3M-92.4M-84.1M-88.6M-54.1M
Net Income5.7M136,000-113.7M-250.2M-65.6M-89.1M-70.3M-98.9M-89.4M-91.6M-54.8M
Per Share Data
EPS (diluted)
Shares Outstanding (dil.)9M8M6M108M92M80M70M41M41M40M39M

Seres Therapeutics, Inc. Income Statement — FAQ

Seres Therapeutics, Inc. (MCRB) income statement over the last 11 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see MCRB's income statement history?

The chart and table above show Seres Therapeutics, Inc.'s income statement by year and by quarter, including the growth rate.